| __timestamp | MiMedx Group, Inc. | Telix Pharmaceuticals Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 118223000 | 28336824 |
| Thursday, January 1, 2015 | 187296000 | 32319194 |
| Friday, January 1, 2016 | 245015000 | 29404631 |
| Sunday, January 1, 2017 | 321139000 | 31769230 |
| Monday, January 1, 2018 | 359111000 | 20439380 |
| Tuesday, January 1, 2019 | 299255000 | 24186536 |
| Wednesday, January 1, 2020 | 248234000 | 4680000 |
| Friday, January 1, 2021 | 258615000 | 4898000 |
| Saturday, January 1, 2022 | 267841000 | 155984000 |
| Sunday, January 1, 2023 | 321477000 | 496659000 |
Cracking the code
In the competitive landscape of pharmaceuticals, Telix Pharmaceuticals Limited and MiMedx Group, Inc. have showcased intriguing revenue trajectories over the past decade. From 2014 to 2023, MiMedx Group, Inc. consistently outperformed Telix in revenue, peaking in 2018 with a 204% increase from its 2014 figures. However, Telix Pharmaceuticals made a remarkable leap in 2023, achieving a revenue surge of over 1,650% compared to its 2014 numbers, surpassing MiMedx for the first time.
This shift highlights Telix's strategic advancements and market penetration, particularly evident in its 2022 to 2023 growth spurt. Meanwhile, MiMedx maintained a steady revenue stream, reflecting its established market presence. As the pharmaceutical industry evolves, these companies exemplify the dynamic nature of revenue growth and market competition.
Comparing Revenue Performance: Eli Lilly and Company or MiMedx Group, Inc.?
Bristol-Myers Squibb Company vs Telix Pharmaceuticals Limited: Annual Revenue Growth Compared
Revenue Insights: Zoetis Inc. and MiMedx Group, Inc. Performance Compared
Genmab A/S or Telix Pharmaceuticals Limited: Who Leads in Yearly Revenue?
Annual Revenue Comparison: Walgreens Boots Alliance, Inc. vs Telix Pharmaceuticals Limited
Breaking Down Revenue Trends: Exelixis, Inc. vs MiMedx Group, Inc.
Ascendis Pharma A/S and MiMedx Group, Inc.: A Comprehensive Revenue Analysis
Who Generates More Revenue? Telix Pharmaceuticals Limited or Ligand Pharmaceuticals Incorporated
Revenue Insights: ImmunityBio, Inc. and MiMedx Group, Inc. Performance Compared
Breaking Down Revenue Trends: Geron Corporation vs MiMedx Group, Inc.
Travere Therapeutics, Inc. vs MiMedx Group, Inc.: Annual Revenue Growth Compared
Revenue Insights: BioCryst Pharmaceuticals, Inc. and MiMedx Group, Inc. Performance Compared